Senior insider sale
Chief Financial Officer at ETON PHARMACEUTICALS, INC. — senior position signals high conviction
$112.4K
6.82K shares
What this filing means
GRUBER JAMES R. plans to sell 6.82K shares of ETON PHARMACEUTICALS, INC. valued at approximately $112.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/14/2026ACC: 0001974078-26-000014
Officer· Chief Financial Officer
Since Apr 2022
6.82K
Shares to sell
$112.4K
Approx. market value
6.47K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Grant
Cash
1/13/2026
6.47KTotal acquired6.47K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/13/2026 | Grant Cash | 6.47K | — |
| Total | 6.47K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
4.52K
Market value
$76.9K
12/12/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
2.29K
Market value
$35.5K
1/14/2026
Total
Units
6.82K
Value
$112.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
12/12/2025 | 4.52K | $76.9K | — | Completed |
| Planned — Approximate Date | ||||
1/14/2026 | 2.29K | $35.5K | NASDAQ | Planned |
| Total | 6.82K | $112.4K | ||